Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin

Journal of Clinical Oncology - United States
doi 10.1200/jco.2008.17.2064
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Survivin Selective Inhibitor YM155 Promotes Cisplatin‑induced Apoptosis in Embryonal Rhabdomyosarcoma

International Journal of Oncology
Cancer ResearchOncology
2016English

A Phase I and Pharmacokinetic Study of Intraperitoneal Topotecan

British Journal of Cancer
Cancer ResearchOncology
2001English

A Phase I and Pharmacodynamic Study of AT9283, a Small-Molecule Inhibitor of Aurora Kinases in Patients With Relapsed/Refractory Leukemia or Myelofibrosis

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2014English

Phase I and Pharmacokinetic Study of D-Verapamil and Doxorubicin

British Journal of Cancer
Cancer ResearchOncology
1991English

Anti-Gd2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells

Pharmaceutical Research
Organic ChemistryBiotechnologyMolecular MedicinePharmacologyPharmaceutical Science
2018English

Phase I Study of SU5416, a Small Molecule Inhibitor of the Vascular Endothelial Growth Factor Receptor (VEGFR) in Refractory Pediatric Central Nervous System Tumors

Pediatric Blood and Cancer
OncologyChild HealthHematologyPerinatologyMedicinePediatrics
2009English

A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2007English

Pharmacodynamic and Pharmacokinetic Profile of S 17092, a New Orally Active Prolyl Endopeptidase Inhibitor, in Elderly Healthy Volunteers. A Phase I Study

British Journal of Clinical Pharmacology
Pharmacology
2001English

Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients With Advanced Solid Tumors

Clinical Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy